Daily non-political popular news in brief.

Diabetes gene carries similar risk to obesity

10-23-2006 · EurekAlert!

Carrying two copies of a common variant of a particular gene doubles your chances of developing diabetes and puts you in a similar risk category to being clinically obese, according to a collaborative study led by UCL (University College London) researchers.

Keywords: diabetes, gene, carries, similar, risk, obesity, diabete, carry

« Previous | Next »

Similar news on "Diabetes gene carries similar risk to obesity":

Major genetic study identifies clearest link yet to obesity risk
04-12-2007 · EurekAlert!
Scientists have identified the most clear genetic link yet to obesity in the general population as part of a major study of diseases funded by the Wellcome Trust, the UK's largest medical research charity. People with two copies of a particular gene variant have a 70 percent higher risk of being obese than those with no copies. Amongst white Europeans, approximately one in six people carry both copies.
Similar news · Read more »
Europe needs collective effort on System Biology, says ESF Task Force
09-10-2007 · EurekAlert!
Most of the diseases which plague humankind today are multifactorial: They are not simply the result of one mutation in one gene, producing one rogue protein that can no longer carry out its job. Diabetes and obesity, for instance, depend on many simultaneous genetic and environmental factors.
Similar news · Read more »
Dietary preferences and patterns may be linked to genes
06-07-2007 · EurekAlert!
Research indicates that the APOA2 gene is associated with food preferences and dietary patterns. About 15 percent of study participants had the genotype CC, which was linked to higher fat intake and almost two times the risk of obesity, as compared to people with more common genotypes of APOA2.
Similar news · Read more »
Metabolic syndrome -- don't blame the belly fat
07-16-2007 · EurekAlert!
Abdominal fat, the spare tire that many of us carry, has long been implicated as a primary suspect in causing the metabolic syndrome, a cluster of conditions that includes the most dangerous heart attack risk factors: prediabetes, diabetes, high blood pressure, and changes in cholesterol. But researchers have found that insulin resistance in skeletal muscle leads to alterations in energy storage that set the stage for the metabolic syndrome.
Similar news · Read more »
Engineered mice provide insight into Alzheimer's disease
01-17-2008 · EurekAlert!
One factor that determines an individual's risk of developing Alzheimer's disease is the version of the APOE gene that they carry. It has been hypothesized that increasing the amount of fat associated with apoE by overexpressing ABCA1 might decrease amyloid deposition in the brain, the hallmark of AD. Support for this hypothesis has now been generated in mice, suggesting that increasing the function of ABCA1 in the brain might benefit individuals with AD.
Similar news · Read more »
A relative of anti-aging gene Klotho also influences metabolic activity, obesity
04-23-2007 · UT Southwestern Medical Center
A relative of the anti-aging gene Klotho helps activate a hormone that can lower blood glucose levels in fat cells of mice, making it a novel target for developing drugs to treat human obesity and diabetes, UT Southwestern Medical Center researchers have found.
Similar news · Read more »
Treating diabetes during pregnancy can break link to childhood obesity
08-28-2007 · EurekAlert!
New Kaiser Permanente study shows treating gestational diabetes can break the link to childhood obesity. The largest study of its kind, this research shows that childhood obesity risk rises with a pregnant woman's blood sugar level and untreated gestational diabetes doubles a child's risk of obesity. Authors looked at 20,000 mothers and children, and found treating gestational diabetes lowers the child's risk of obesity to same level of a mother with normal blood sugar levels.
Similar news · Read more »
Advance in understanding of blood pressure gene could lead to new treatments
02-04-2007 · EurekAlert!
Research by scientists at UCL (University College London) has clearly demonstrated for the first time the structure and function of a gene crucial to the regulation of blood pressure. The discovery could be important in the search for new treatments for illnesses such as heart disease, the UK's biggest killer. In a paper published online today in Nature Medicine, the team, led by Professor Patrick Vallance and Dr James Leiper, UCL Department of Medicine, reveal the role of the human gene dimethylarginine dimethylaminohydrolase (DDAH), showing that loss of DDAH activity disrupts nitric oxide (NO) production. NO is critical in the regulation of blood pressure, nervous system functions and the immune system. The role of DDAH is to break down modified amino acids (Asymmetric dimethylarginine (ADMA) and monomethyl arginine (L-NMMA)) that are produced by the body and have been shown to inhibit NO synthase. These molecules accumulate in various disease states including diabetes, renal failure and pulmonary and systemic hypertension, and their concentration in plasma (the fluid component of blood) is strongly predicative of cardiovascular disease and death. In a healthy human body, the majority of ADMA is eliminated through active metabolism by DDAH. Scientists have hypothesised that if DDAH function is impaired, NO production is reduced, and that this could be an important feature of increased cardiovascular risk. To examine this pathway in more detail, the researchers deleted the DDAH gene in mice. These mice went on to develop hypertension, or high blood pressure. They also designed specific inhibitors (small molecules) which bind to the active site of human DDAH. These small molecule inhibitors also induced hypertension in mice, confirming the importance of DDAH in the regulation of blood pressure. Dr Leiper, UCL Medicine, said: “These genetic and chemical approaches to disrupt DDAH showed remarkably consistent results, and provide compelling evidence that loss of DDAH function increases the concentration of ADMA and thereby disrupts vascular NO signalling. “There has been considerable scientific interest in this pathway and the role of ADMA as a novel risk factor, but so far there's been little evidence to support the idea that it's a cause of disease, rather than just a marker. Genes and their pathways are crucial to our understanding of cardiovascular disease and a better understanding of DDAH-1 could lead to important new treatments. “It could help us to establish if genetic variation predisposes certain people to these diseases, or whether environmental factors exert some of their effects through modulation of DDAH activity. “Our research also shows that this pathway could be harnessed therapeutically to limit production of NO in certain situations where too much nitric oxide is a bad thing; for example, hypotension and septic shock. These are some of the biggest problems in intensive care medicine and there is a huge unmet need for drug treatments.” The study, which was carried out at UCL's Rayne Institute, was funded by grants from the British Heart Foundation, the Wellcome Trust and the Medical Research Council. Professor Jeremy Pearson, Associate Medical Director of the British Heart Foundation, said: "The unexpected finding in the 1980s that a simple gas, nitric oxide (NO), is made by cells in the blood vessel wall and is a powerful control of blood vessel relaxation led to the award of the Nobel Prize in 1998 to its discoverers. "More recently, there has been increasing evidence that impairment of NO production is likely to be an important factor in the development of heart and circulatory disease, but the mechanisms responsible are not fully understood. "This study suggests for the first time that the loss of the activity of the enzyme DDAH-1 leads to reduced NO production and may cause heart and circulatory disease. These findings are likely to be important in the search for new ways to optimise the health of our blood vessels." ### Notes for Editors 1. For more information, please contact Ruth Metcalfe in the UCL Media Relations Office on tel: +44 (0)20 7679 9739, mobile: +44 (0)7990 675 947, out of hours: +44 (0)7917 271 364, e-mail: r.metcalfe@ucl.ac.uk2. 'Disruption of methylarginine metabolism impairs vascular homeostasis' is published in the February issue of the journal Nature Medicine. Advance online publication is embargoed to 18.00 GMT (13.00 US Eastern) Sunday 4 February 2007. Journalists can obtain copies of the paper by contacting the UCL Media Relations Office.3. The study was funded by the British Heart Foundation, the Wellcome Trust and the Medical Research Council. About UCL Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. In the government's most recent Research Assessment Exercise, 59 UCL departments achieved top ratings of 5* and 5, indicating research quality of international excellence. UCL is the fourth-ranked UK university in the 2006 league table of the top 500 world universities produced by the Shanghai Jiao Tong University. UCL alumni include Mahatma Gandhi (Laws 1889, Indian political and spiritual leader); Jonathan Dimbleby (Philosophy 1969, writer and television presenter); Junichiro Koizumi (Economics 1969, Prime Minister of Japan); Lord Woolf (Laws 1954, Lord Chief Justice of England & Wales); Alexander Graham Bell (Phonetics 1860s, inventor of the telephone), and members of the band Coldplay.
Similar news · Read more »
Esophageal cancer rates climb with obesity; U-M study finds esophagectomy safe in obese patients
01-30-2007 · EurekAlert!
The rapidly climbing obesity rates in the United States have created a higher risk of esophageal cancer linked to reflux disease. According to a new study at the University of Michigan Health System, obese patients who underwent a procedure called transhiatal esophagectomy primarily for esophageal cancer had outcomes similar to their lean counterparts.
Similar news · Read more »
Obesity high among Baltimore's homeless, Johns Hopkins researchers say
03-14-2007 · EurekAlert!
A small but telling study from the Johns Hopkins Children's Center reveals an ominous trend: more than expected, obesity shadows Baltimore's homeless children and their caregivers, putting them at high risk for heart disease, stroke and type 2 diabetes, among other conditions.
Similar news · Read more »